|
Volumn 161, Issue 9, 2004, Pages 1722-1723
|
Potential for misuse of sedatives [11] (multiple letters)
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
BENZODIAZEPINE DERIVATIVE;
BENZODIAZEPINE RECEPTOR STIMULATING AGENT;
HYPNOTIC SEDATIVE AGENT;
SEDATIVE AGENT;
AGORAPHOBIA;
BEHAVIOR THERAPY;
CLINICAL PRACTICE;
COGNITIVE THERAPY;
COMORBIDITY;
DRUG ABUSE;
DRUG DEPENDENCE;
DRUG MISUSE;
EPIDEMIOLOGICAL DATA;
HEALTH SURVEY;
HIGH RISK PATIENT;
HUMAN;
INSOMNIA;
LETTER;
LONG TERM CARE;
PANIC;
PATIENT SELECTION;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SOCIAL PHOBIA;
SUICIDAL BEHAVIOR;
SUICIDE ATTEMPT;
ANXIETY DISORDERS;
BENZODIAZEPINES;
CROSS-SECTIONAL STUDIES;
DEPRESSIVE DISORDER;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
HYPNOTICS AND SEDATIVES;
PREVALENCE;
RECEPTORS, GABA-A;
RESEARCH DESIGN;
RISK FACTORS;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
SUBSTANCE-RELATED DISORDERS;
SUICIDE;
UNITED STATES;
|
EID: 4444358848
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (4)
|
References (0)
|